AzTrials
AzTrials

Premature BirthPARENNCT06811064

Involving Family Stakeholders in the NICU: a New Perspective to Improve Quality of Life. PAREN

An observational study of Premature Birth, run by Assistance Publique Hopitaux De Marseille at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Introduction Thanks to medical advances in neonatal care, the majority of children admitted to the neonatal intensive care unit (NICU) survive and enjoy a good quality of life. At the same time, medical practices and philosophy of neonatal care have changed and families are playing an increasingly important role in… Read more about this study

Who is it for?
Ages Up to 6 months
Conditions the study is for
Premature Birth
What is being tested?
Testimony video
How many people
1,008 participants
Where
1 siteFrance
Study dates
30 Sep 2025to 29 Feb 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 6 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: premature newborn

Who may be able to join

  • Premature newborn (<37 weeks of amenorrhoea)
  • Newborn whose parents are aged 18 or over
  • Newborns who have spent at least one week in a neonatal intensive care unit,
  • Newborn baby hospitalised in one of the neonatology/intensive care unit
  • Newborn for whom both or one of the two parents have expressed their non-opposition to taking part in the study or Newborn for whom the only legal representative (single-parent family) has expressed his/her non-opposition to taking part in the study.

Who cannot join

  • Newborns at term (≥ 37 SA);
  • Newborns in which both or one of the parents refuse to participate or newborns in which the only legal representative (single-parent family) has expressed opposition to participating in the study.
  • Newborn whose two parents or one of them withdraws their non-opposition
  • Newborn transferred to another neonatal intensive care unit during hospital stay;
  • Newborn child who dies during hospitalisation or after discharge up to the one-year visit.
  • Newborn lost to follow-up at 1 year.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Barthélémy TOSELLO, MD, PhD contact

04 91 96 83 00 ext. + 33

barthelemy.tosello@ap-hm.fr

Claire MORANDO, MD contact

claire.morando@ap-hm.fr

France1 site
  • Assistance Publique des Hôpitaux de Marseille (APHM)

    Marseille, 13015

    Barthélémy TOSELLO, MD, PhD, 4 91 96 83 00 ext. +33, barthelemy.tosello@ap-hm.fr

Other trials in France

About this study

Official title: Resource Parents in Neonatology: Innovative Partnership Practices to Improve Quality of Life After Returning Home

Introduction Thanks to medical advances in neonatal care, the majority of children admitted to the neonatal intensive care unit (NICU) survive and enjoy a good quality of life. At the same time, medical practices and philosophy of neonatal care have changed and families are playing an increasingly important role in their child's care. However, stress and anxiety generated by hospitalization and complex technologies of neonatal intensive care units may be an obstacle to integrate parents and help them take ownership of their role. A number of measures have been established to improve the experience of parents in neonatology, such as multidisciplinary care, involving psychologists, social workers, spiritual care workers, psychomotor therapists and physiotherapists.

Among these interventions, the introduction of resource parents (RPs), parents who have previously been involved in neonatology, is a new initiative that is growing rapidly in North America. These RPs bring a unique perspective based on their experiential knowledge. This partnership model is still underdeveloped in France, and its impact on parents' quality of life and early interactions with their children has been little studied or described.

Read more

Method Our aim is therefore to develop a PR intervention in neonatology units and measure its impact in the short and medium term, with a prospective multicenter step wedge study.

The chosen intervention will be co-constructed with PRs. It will take the form of testimonial videos focusing on one of the key moments in the care of newborn babies: the transition from different neonatology units. These videos will then be viewed by parents of hospitalized newborn in the units at the time of their transition. A survey assessing the parents' Self Perceived Efficacity in taking care of their child will be administered when the child transitions to the neonatal unit and then again when the child is discharged from the hospital. At the one-year old visit, the families' quality of life will be assessed using another standardized survey: the Pediatric Quality of Life Inventory (PedsQLTM2.0) - Family Impact Module.

Perspective Our hypothesis is that a PR intervention at a key point in the newborn's care pathway can help parenthood and have a positive impact on early interactions and quality of life at 1 year.

Conditions
Premature Birth
Being tested
Testimony video
Keywords
resource parents, quality of life, premature newborn, neonatal intensive care unit
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Testimony videoOther

    A testimonial video on the experiences of parents of premature babies during the transfer of their newborn from the intensive care unit to the neonatal unit. This video will be performed with the collaboration of the carers and resource parents.

Study groups in NCT06811064
Study groupRoleWhat they receive
Intervention of resource parents for parents of hospitalised premature new bornParents of hospitalised premature new born watch a testimony video pf other parent who experienced hospitalization of their premature new born
Receives: Other: Testimony video
without intervention of resource parents for parents of hospitalised premature new bornParents of hospitalised premature new born do not watch a testimony video of other parent who experienced hospitalization of their premature new born

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluate the the quality of life of parent with premature child at one year corrected age

    Questionnaire PedsQL

    Measured: At the one year anniversary (12 months corrected age) of the premature child

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2025
  2. Study start30 Sep 2025 (estimated)
  3. Primary completion29 Feb 2028 (estimated)
  4. Study completion29 Feb 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Prospective
Enrolment
1,008 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06811064
Sponsor's protocol ID
2022-A01087-36
Acronym
PAREN
Status last verified
Jan 2025
First submitted
31 Jan 2025
Last updated
6 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Premature Birth, run by Assistance Publique Hopitaux De Marseille at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 6 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Barthélémy TOSELLO, MD, PhD (04 91 96 83 00 ext. + 33, barthelemy.tosello@ap-hm.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluate the the quality of life of parent with premature child at one year corrected age (time frame: At the one year anniversary (12 months corrected age) of the premature child). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in